Vanguard Capital Management’s Prothena PRTA Stock Holding History
Bought
Maintained
Sold
Other funds holding PRTA
Vanguard Capital Management's PRTA Position: Q3 2026 in Review
Vanguard Capital Management reduced its Prothena (PRTA) stake by 3.6% in Q3 2026, selling an estimated $155K and leaving 462,553 shares worth $3.88M. The position accounts for ﹤0.01% of the portfolio, ranked #3161.
Vanguard Capital Management first reported a position in PRTA in Q1 2026 and has held it in 3 quarters since. The position peaked at $4.71M in Q1 2026. 182 funds tracked by Wall St. Rank hold PRTA as of Q3 2026.
- Vanguard Capital Management held 462,553 shares of Prothena worth $3.88M as of Q3 2026.
- Vanguard Capital Management sold 17,392 Prothena shares in Q3 2026, an estimated $155K.
- Prothena made up ﹤0.01% of Vanguard Capital Management's portfolio in Q3 2026, its #3161 holding.
- Vanguard Capital Management first reported a position in Prothena in Q1 2026 and has held it in 3 quarters since.
- Vanguard Capital Management's Prothena position peaked at $4.71M in Q1 2026.
- 182 funds tracked by Wall St. Rank held Prothena as of Q3 2026.
Based on Vanguard Capital Management's 13F filing for Q3 2026, filed 13 Nov 2026.